Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | CHUNG, BC | - |
dc.contributor.author | KIM, DH | - |
dc.contributor.author | JUNG, BH | - |
dc.contributor.author | EOM, K | - |
dc.contributor.author | SLIKKER, W | - |
dc.contributor.author | PARK, J | - |
dc.date.accessioned | 2024-01-21T21:38:23Z | - |
dc.date.available | 2024-01-21T21:38:23Z | - |
dc.date.created | 2021-09-01 | - |
dc.date.issued | 1994-05 | - |
dc.identifier.issn | 0049-8254 | - |
dc.identifier.uri | https://pubs.kist.re.kr/handle/201004/145595 | - |
dc.description.abstract | 1. The metabolism of pyrilamine, 2-[4-methoxybenzyl-(2-dimethylaminoelhyl) amino] pyridine, was studied in adult male volunteers after a single oral dose of 50 mg. 2. Solvent extracts of urine obtained with or without enzyme hydrolysis were analysed by gc/ms after derivatization with MSTFA/TM SCI (N-methyl-N-trimethylsilyl-trifluoroacetamidel-trimethyl chlorosilane). The structure of metabolites were determined based on EI mass spectra and confirmed with those of authentic standards. 3. Conjugated metabolites identified in the urine were pyrilamine, O-desmethylpyril amine, and ring hydroxylated derivatives of pyrilamine. O-desmethylpyrilamine was also detected in low abundance as a free form. 4. These metabolites observed in human urine were quite different from those previously reported in rat. | - |
dc.language | English | - |
dc.publisher | TAYLOR & FRANCIS LTD | - |
dc.subject | MALEATE | - |
dc.subject | ANTIHISTAMINES | - |
dc.subject | TRIPELENNAMINE | - |
dc.subject | DRUGS | - |
dc.subject | ASSAY | - |
dc.subject | RAT | - |
dc.title | IDENTIFICATION OF URINARY METABOLITES OF PYRILAMINE AFTER ORAL-ADMINISTRATION TO MAN | - |
dc.type | Article | - |
dc.identifier.doi | 10.3109/00498259409043248 | - |
dc.description.journalClass | 1 | - |
dc.identifier.bibliographicCitation | XENOBIOTICA, v.24, no.5, pp.451 - 459 | - |
dc.citation.title | XENOBIOTICA | - |
dc.citation.volume | 24 | - |
dc.citation.number | 5 | - |
dc.citation.startPage | 451 | - |
dc.citation.endPage | 459 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.identifier.wosid | A1994NN02900007 | - |
dc.identifier.scopusid | 2-s2.0-0028335006 | - |
dc.relation.journalWebOfScienceCategory | Pharmacology & Pharmacy | - |
dc.relation.journalWebOfScienceCategory | Toxicology | - |
dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
dc.relation.journalResearchArea | Toxicology | - |
dc.type.docType | Article | - |
dc.subject.keywordPlus | MALEATE | - |
dc.subject.keywordPlus | ANTIHISTAMINES | - |
dc.subject.keywordPlus | TRIPELENNAMINE | - |
dc.subject.keywordPlus | DRUGS | - |
dc.subject.keywordPlus | ASSAY | - |
dc.subject.keywordPlus | RAT | - |
dc.subject.keywordAuthor | pyrilamine | - |
dc.subject.keywordAuthor | metabolite | - |
dc.subject.keywordAuthor | GC-MS | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.